REFERENCE · RECOVERY

Recovery Techniques for Functional Facial Symptoms

Functional facial symptoms require an individualized plan because **droop can describe different mechanisms**. Sustained downward lip pulling is usually treated as muscle overactivity; true weakness, impaired mouth closure, ptosis, eye closure, jaw or tongue symptoms may need different rehabilitation and safety measures. (*citations* [1](#citation-1), [5](#citation-5), [6](#citation-6), [8](#citation-8))

Refers to:

For a fuller description of this symptom and the diagnostic techniques used to assess it, see Understanding & Diagnosis.

  • facial pulling, spasm or dystonia and apparent droop caused by overactivity;
  • assessed functional facial weakness, eye closure or ptosis; and
  • lip, jaw or tongue movement and mouth-seal difficulty when facial motor control is central.

Scope boundary: This category may overlap dystonia, limb weakness, speech or swallowing, but its diagnostic and recovery techniques must follow the actual facial mechanism—overactive pulling, weakness, eye closure, mouth control or another assessed pattern. Limb-only symptoms use the partial-weakness or paralysis page.

Also described as: functional facial spasm, functional facial dystonia, facial pulling, apparent facial droop, functional facial weakness, functional ptosis and functional eye closure.

The facial-specific treatment evidence is very limited. The research reviewed contains specialist clinical guidance and one published episodic facial-dystonia case inside a broader case series and literature review—not a facial-symptom randomized trial. [7][8]

Community reports


For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —

For the Person With FND

Techniques used in rehabilitation

Open all ten detailed pages. These preserve the original entries; the number is not a count of independently validated treatments.

  1. Understanding What Your Face Is Doing — When a clinician has diagnosed a functional facial symptom and you need to understand what the finding means for care. [Specialist clinical guidance; explanation is a foundation for care]
  2. Building a Rehabilitation Plan Around Daily Life — When facial symptoms affect several daily activities and you need help choosing a practical starting point. [Broader motor rehabilitation evidence; facial-specific effectiveness uncertain]
  3. Making a Plan for Familiar Facial Episodes — When an assessed facial symptom comes in episodes and it would help to decide in advance what you and others will do. [One facial case within a case series; individualized care planning]
  4. Finding Easier Movement During Conversation — When a therapist has noticed that a facial movement is easier during an ordinary activity than during deliberate testing. [Clinical motor-retraining guidance; facial component efficacy untested]
  5. Choosing a Facial or Mouth Task With Your Therapist — When assessment has identified one movement or everyday function that could be practised safely. [Individualized clinical guidance; no standard facial exercise prescription]
  6. Planning Gentle Practice Around an Assessed Trigger — When an assessed movement or lighting situation reliably brings on familiar symptoms and a clinician considers planned practice appropriate. [Specialist guidance; facial exposure efficacy uncertain]
  7. Making Your Face, Jaw and Neck More Comfortable — When pulling or an effort to correct it leaves your jaw, face or neck uncomfortable. [Clinical comfort guidance; direct facial-treatment evidence limited]
  8. Protecting Eating, Vision and Communication — When facial symptoms interfere with mouth closure, eating, communication or usable vision. [Clinical safety and access support; recovery does not require removing aids]
  9. Keeping Other Causes and Conditions in the Care Plan — When pain, eye symptoms, jaw problems, medicines or another condition may be contributing alongside FND. [Clinical differential assessment and coordinated care]
  10. Discussing Botulinum Toxin With a Specialist — When a specialist proposes an injection for a specific facial pattern or a coexisting movement disorder. [Uncertain selected use; evidence does not support routine injection for functional facial symptoms]

When a familiar episode begins

  1. Check safety before technique. Stop driving, walking without adequate vision, eating or another hazardous activity.
  2. Compare with the established pattern. New, sudden or clearly different facial droop needs urgent assessment rather than the usual FND plan.
  3. Use one rehearsed entry point. This might be a grounding cue, body relaxation, attention on an external task, comfortable positioning or one therapist-selected facial or speech movement.
  4. Avoid force and repeated testing. Do not pull the mouth corner, stretch the jaw, hold an eyelid open or perform a long sequence of facial movements to prove that control has returned.
  5. Support drooling without shame. Sit upright when safe, use tissues and protect irritated skin. Do not experiment with food or drink when coughing, choking, wet voice or impaired swallowing is present.
  6. Return gradually. When the episode eases, resume one safe, meaningful activity before increasing demand.

If there is no warning or not enough control to use a technique, the plan should focus on environmental safety, communication and comfort until a useful entry point returns.

A low-risk starting practice

Before practising, obtain a clear diagnosis of the facial pattern. Choose one ordinary, previously safe task the treating clinician has identified—such as an easy speech sound or a small comfortable expression—and use the least effort needed. Stop if there is pain, jaw locking, visual loss, choking, breathing difficulty, a new neurological symptom or a sustained deterioration. Without an individualized plan, recording the pattern and avoiding force is safer than copying a facial-palsy routine from the internet.

Ask for urgent help or reassessment when

Facial droop is new, sudden or distinctly changed; occurs with new limb weakness, speech or understanding difficulty, severe headache, double vision, loss of balance, confusion or reduced consciousness; or follows a head injury. Reassessment is also needed for inability to close an eye, eye pain or injury, progressive ptosis, jaw locking, major swelling, new medication-related movements, persistent drooling, choking, a wet voice, dehydration, weight loss or breathing difficulty.


For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —

For Family, Friends, and Other Supporters

  • Treat a new facial droop as a possible medical emergency; do not assume it is FND.
  • During an established episode, ask before touching the person’s face, jaw or neck.
  • Offer the agreed cue once and reduce pressure to speak, smile or “show” that the face can move.
  • Help with tissues, skin care, communication, vision and privacy without making drooling or facial appearance a joke unless the person initiates that humour.
  • Do not force food or drink when mouth control or swallowing is uncertain.
  • Record onset, duration, visible muscle pulling, associated symptoms and recovery when the person wants this information kept.
  • Support accommodations and continuing care when facial symptoms remain persistent; the value of help is not limited to making the face look symmetrical.

During a longer episode or flare

Move from repeated symptom correction to a simple sequence: safety → one agreed cue or support → communication and comfort → gradual return. If the episode does not match the established pattern, or speech, swallowing, breathing, vision or awareness changes in a concerning way, seek reassessment.


For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —

For Clinicians and the Care Team

Confirm whether the treatment target is dystonic pulling, facial weakness, active eye closure, ptosis, jaw or tongue movement, mouth seal, speech, swallowing or a combination. Demonstrate the positive finding to the patient without implying that variability means voluntariness. A functional facial symptom should not prevent investigation or treatment of a coexisting cranial nerve, movement, neuromuscular, vascular, dental, eye or swallowing disorder.

Build a phenotype-specific plan

  1. Record the movement pattern, active muscles, duration, triggers, warning symptoms, associated awareness or whole-body symptoms, pain and preserved functions.
  2. Select one useful rehabilitation entry point: automatic expression, external focus, a functional mouth or speech task, grounding at a warning, relaxation of broader muscle activity, or carefully graded trigger practice.
  3. Rehearse the entry point between episodes, then reduce it to a portable onset sequence.
  4. Decide explicitly whether a mirror helps, increases self-monitoring or worsens the movement. The answer may differ between patients and over time.
  5. Coordinate speech-language therapy when lip seal, drooling, speech, chewing or swallowing is affected; obtain instrumental swallowing assessment when clinically indicated.
  6. Include eye protection and ophthalmic or movement-disorder review when eye closure or ptosis threatens vision or corneal safety.
  7. Measure outcomes that matter to the patient: eating and drinking safety, speech access, eye comfort, pain, episode frequency or duration, community participation, embarrassment and quality of life—not facial symmetry alone.
  8. When improvement is limited, continue symptom relief, skin and dental care, communication and swallowing support, accessibility, participation planning and agreed medical reassessment.

The published facial rehabilitation example involved one person with bilateral episodic facial spasms and variable dissociation. Trigger/prodrome identification, early grounding, relaxation and modified CBT were delivered together, so the report cannot identify which component helped or predict another person’s outcome. Broader functional-dystonia literature consists mainly of case reports and case series, and a gold-standard pathway is not established.

Community reports: what people try

These short quotations are lived-experience candidates, not treatment evidence or instructions. Four come from one recent public comment, so they show one person’s routine rather than independent repetition. The other accounts show that community experience can also conflict with or qualify a proposed technique. Usernames and unrelated details are omitted.

“massaging muscles, gently lifting the corner of my mouth, tapping my skin”

— One person describing what they try for facial droop and drooling. They also said they stop when touch feels unpleasant or worsens symptoms. Source

“mouthing the alphabet and thinking about what shapes each letter requires”

— The same person describing small facial movements combined with a language task. They cautioned that focusing on movement might worsen symptoms for someone else. Source

“i never do any of this in a mirror … with some sort of background distraction”

— The same person reporting that mirrors worsen their symptoms and external attention feels more useful. This is individual experience; some rehabilitation uses mirrors selectively. Source

“i’m right here in the drool crew with you!”

— The same commenter offering solidarity and humour rather than a medical claim. Source

“I often put a sleep mask on and turn the lights off to help with it.”

— A different person describing short-term sensory reduction during eyelid fluttering. Acute comfort does not establish that long-term light avoidance is helpful; specialist guidance may instead use graded light exposure for selected patients. Source

“I use Botox and it hasn’t seemed to impact it.”

— Another person reporting that Botox used for migraine did not change their facial tics or spasms. The writer’s terms do not establish whether these were tics, dystonia or another movement; this account cannot be used as functional-tic treatment evidence. This is one account, not an effectiveness study. Source

“It stopped the spasming for about three months … then wore off and my dystonia returned.”

— A different person reporting temporary change after Botox was injected into the spasming facial muscle. They also described a temporarily crooked smile. This is an individual benefit-and-drawback account, not evidence for routine treatment. Source

What these accounts add—and do not add

The community material raises useful questions for clinical testing: whether light touch helps or overloads; whether an external language task makes facial movement easier; whether mirrors help or increase symptom focus; and how to protect vision and dignity during episodes. The reports do not establish massage, lifting the mouth corner, alphabet practice, darkness or Botox as treatments. Those ideas remain clearly separated from the research-supported and consensus-guided plan above.

Community reports

Motor and vocal tic-like symptoms

Facial tic-like movements need their own assessment. A facial location does not make a tic equivalent to dystonia, weakness or spasm. See the dedicated functional-tics page.

Source for the tic boundary: Malaty IA, Anderson S, Bennett SM, et al. Diagnosis and management of functional tic-like phenomena. Journal of Clinical Medicine. 2022;11(21):6470. FND-CIT-0110; source.

Previous symptom: PPPD recovery overview · PPPD flare and review plan


For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —

Research and Sources

There is no located controlled trial of a facial-symptom-specific FND rehabilitation program. Gros and colleagues reported one person with episodic functional facial dystonia within a four-case series and reviewed a functional-dystonia literature made up mainly of case reports and series. Broader functional motor rehabilitation principles come from physiotherapy consensus and a phase 3 specialist-physiotherapy trial whose reported outcomes were not facial-specific. Functional-dystonia and speech-language guidance supports multidisciplinary, phenotype-specific care but describes little direct evidence for individual facial techniques. Retrospective facial and stomatognathic cohorts contain uncontrolled treatment observations, including some reported improvement after botulinum toxin, but do not test efficacy. Neurosymptoms provides facial-specific specialist guidance on explanation, triggers, graded exposure and Botox, but it is an expert educational source rather than a trial. [1][2][3][4][5][6][7][8]

The community quotations above are included for reviewable lived-experience wording and practical ideas. They do not satisfy the project’s two-independent-report rule for a new repeated community-report technique and are not entered in the technique index as established community practices.

A small randomized pilot in broader persistent functional dystonia also found no added benefit from botulinum toxin over placebo before CBT. It was not a facial-specific study. [9]

Citation table

Citation Full citation
[1] Frucht L, Perez DL, Callahan J, et al. Functional dystonia: differentiation from primary dystonia and multidisciplinary treatments. Frontiers in Neurology. 2021;11:605262. FND-CIT-0021. https://doi.org/10.3389/fneur.2020.605262
[2] Baker J, Barnett C, Cavalli L, et al. Management of functional communication, swallowing, cough and related disorders: consensus recommendations for speech and language therapy. Journal of Neurology, Neurosurgery & Psychiatry. 2021;92(10):1112–1125. FND-CIT-0025. https://doi.org/10.1136/jnnp-2021-326767
[3] Nielsen G, Stone J, Matthews A, et al. Physiotherapy for functional motor disorders: a consensus recommendation. Journal of Neurology, Neurosurgery & Psychiatry. 2015;86(10):1113–1119. FND-CIT-0028. https://doi.org/10.1136/jnnp-2014-309255
[4] Nielsen G, Stone J, Lee TC, et al.; Physio4FMD study group. Specialist physiotherapy for functional motor disorder in England and Scotland (Physio4FMD): a pragmatic, multicentre, phase 3 randomised controlled trial. The Lancet Neurology. 2024;23(7):675–686. FND-CIT-0029. https://doi.org/10.1016/S1474-4422(24)00135-2
[5] Fasano A, Valadas A, Bhatia KP, et al. Psychogenic facial movement disorders: clinical features and associated conditions. Movement Disorders. 2012;27(12):1544–1551. FND-CIT-0052. https://doi.org/10.1002/mds.25190
[6] Yoshida K. Clinical characteristics of functional movement disorders in the stomatognathic system. Frontiers in Neurology. 2020;11:123. FND-CIT-0053. https://doi.org/10.3389/fneur.2020.00123
[7] Gros P, Bhatt H, Gilmour GS, Lidstone SC. Rehabilitation for functional dystonia: cases and review of the literature. Movement Disorders Clinical Practice. 2024;11(8):1018–1024. FND-CIT-0055. https://doi.org/10.1002/mdc3.14121
[8] Stone J. Functional facial symptoms. Neurosymptoms.org. Accessed September 1, 2026. FND-CIT-0056. https://neurosymptoms.org/en/symptoms/fnd-symptoms/functional-facial-symptoms/
[9] Vizcarra JA, Lopez-Castellanos JR, Dwivedi AK, et al. OnabotulinumtoxinA and cognitive behavioral therapy in functional dystonia: a pilot randomized clinical trial. Parkinsonism & Related Disorders. 2019;63:174–178. DOI. FND-CIT-0093.

Community sources

Clinical sources rechecked September 22, 2026; existing community material last searched September 1, 2026 · Movement-disorders, stroke, speech-language, lived-experience and accessibility review pending


For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —